Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mart Ustav Jr"'
Autor:
Kushal Suryamohan, Devan Diwanji, Eric W. Stawiski, Ravi Gupta, Shane Miersch, Jiang Liu, Chao Chen, Ying-Ping Jiang, Frederic A. Fellouse, J. Fah Sathirapongsasuti, Patrick K. Albers, Tanneeru Deepak, Reza Saberianfar, Aakrosh Ratan, Gavin Washburn, Monika Mis, Devi Santhosh, Sneha Somasekar, G. H. Hiranjith, Derek Vargas, Sangeetha Mohan, Sameer Phalke, Boney Kuriakose, Aju Antony, Mart Ustav Jr, Stephan C. Schuster, Sachdev Sidhu, Jagath R. Junutula, Natalia Jura, Somasekar Seshagiri
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-11 (2021)
Suryamohan, Diwanji, Stawiski et al. identify natural ACE2 variants that are predicted to alter virus–host interactions. They find that soluble ACE2 K26R and T92I variants are more effective in blocking the entry of SARS-CoV-2 S-protein pseudotyped
Externí odkaz:
https://doaj.org/article/32225ac91a454b1683c6a373e209aa04
Autor:
Kiira Gildemann, Mari-Liis Tsernant, Laura Liivand, Retti Ennomäe, Väino Poikalainen, Lembit Lepasalu, Siimu Rom, Ants Kavak, Robert Marsden Cox, Josef Dieter Wolf, Carolin Maria Lieber, Richard Karl Plemper, Andres Männik, Mart Ustav, Jr., Mart Ustav, Joachim Matthias Gerhold
Publikováno v:
iScience, Vol 27, Iss 7, Pp 110326- (2024)
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread in the population. We recently reported the production of bovine colostrum-derived antibodies that can neutralize the virus. These have been formulated into a n
Externí odkaz:
https://doaj.org/article/4a26311eb5124ea19ecbfdef3d1c104d
Autor:
Erlend Ravlo, Aleksandr Ianevski, Eirin Starheim, Wei Wang, Ping Ji, Hilde Lysvand, Teemu Smura, Gaily Kivi, Maia-Liisa Voolaid, Kati Plaan, Mart Ustav, Mart Ustav, Jr., Eva Zusinaite, Tanel Tenson, Reet Kurg, Valentyn Oksenych, Kirsti Walstad, Svein Arne Nordbø, Mari Kaarbø, Karin Ernits, Magnar Bjørås, Denis E. Kainov, Mona Høysæter Fenstad
Publikováno v:
International Journal of Infectious Diseases, Vol 137, Iss , Pp 75-78 (2023)
Vaccinated convalescents do not develop severe COVID-19 after infection with new SARS-CoV-2 variants. We questioned how messenger RNA (mRNA) vaccination of convalescents provides protection from emerging virus variants. From the cohort of 71 convales
Externí odkaz:
https://doaj.org/article/8098c1ee0a8344b78dfaa169d2000625